Globus Medical, Inc. (NYSE: GMED) has announced a major leadership transition alongside preliminary second-quarter results that show continued momentum in its core spine and enabling technologies ...

Keith brings a sharp strategic mindset and a results-orientated leadership style with a clear understanding of how to drive performance across an organization,” said David C. Paul, Globus Medical ...

Globus Medical, Inc. GMED recently introduced DuraPro, a next-generation oscillating system with Excelsius navigation capabilities. DuraPro is the latest addition to the company’s Power Portfolio, ...

MedTech company Precisis has appointed Steven Griffiths as its Vice President of European Sales, a newly created role aimed at accelerating the company’s growth across Europe.

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results ...

The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped Street forecasts.

The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $104 ...

The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $104 ...

Nevro's full-year 2024 worldwide revenue was $408.5 million, a decrease of 3.9% as reported and 4.0% on a constant currency basis, compared with $425.2 million for full-year 2023.